Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07583563
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
Sponsor: Camurus AB
View on ClinicalTrials.gov
Summary
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Official title: A Multi-Center, Multinational, Observational Study of Octreotide Subcutaneous Depot for the Treatment of Patients With Acromegaly
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-05
Completion Date
2029-05
Last Updated
2026-05-13
Healthy Volunteers
No
Conditions
Interventions
DRUG
Octreotide subcutaneous depot
Commercially available octreotide subcutaneous depot treatment administered by participants for a maximum duration up to 2 years in the study